Cargando…
Risk stratification of patients with chronic heart failure using cardiac iodine‐123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction
AIMS: Right ventricular (RV) systolic dysfunction has been shown to be an independent predictor of clinical outcome in patients with chronic heart failure (CHF), and cardiac metaiodobenzylguanidine (MIBG) imaging also provides prognostic information. We aimed to evaluate the long‐term predictive val...
Autores principales: | Tamaki, Shunsuke, Yamada, Takahisa, Morita, Takashi, Furukawa, Yoshio, Iwasaki, Yusuke, Kawasaki, Masato, Kikuchi, Atsushi, Kondo, Takumi, Kawai, Tsutomu, Takahashi, Satoshi, Ishimi, Masashi, Hakui, Hideyuki, Ozaki, Tatsuhisa, Sato, Yoshihiro, Seo, Masahiro, Sakata, Yasushi, Fukunami, Masatake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042054/ https://www.ncbi.nlm.nih.gov/pubmed/27708857 http://dx.doi.org/10.1002/ehf2.12057 |
Ejemplares similares
-
Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co‐morbid burden in acute decompensated heart failure
por: Kayama, Kiyomi, et al.
Publicado: (2021) -
Can cardiac iodine-123 metaiodobenzylguanidine imaging contribute to risk stratification in heart failure patients?
por: Bax, Jeroen J., et al.
Publicado: (2008) -
Extraction of a “floating leadless pacemaker”: A case report
por: Kawasaki, Masato, et al.
Publicado: (2020) -
The Potential Role of Iodine-123 Metaiodobenzylguanidine Imaging for Identifying Sustained Ventricular Tachycardia in Patients with Cardiomyopathy
por: Klein, Thomas, et al.
Publicado: (2013) -
Iodine-123-metaiodobenzylguanidine cardiac SPECT imaging in the qualification of heart failure patients for ICD implantation
por: Teresińska, Anna
Publicado: (2018)